Dr. Mark Leo Graham II, MD
- Medicare services, 2024
- 1,396
- Medicare patients, 2024
- 524
- Part D claims, 2024
- 2,588
- Publications
- 7
- Clinical trials
- 10
- Practice address
- 3000 New Bern Ave, Raleigh, NC 27610
- Practice phone
- Call (919) 350-8000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Graham's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Mark Leo Graham II is a hematologist and oncologist in Raleigh, North Carolina
Dr. Graham practices at WakeMed Raleigh Campus in Raleigh, North Carolina, part of Advocate Health.
Dr. Graham's NPI, 1760481667, was assigned on July 21, 2005. Dr. Graham graduated from Mayo Medical School in 1982. Dr. Graham holds North Carolina license 39812.
- NPI
- 1760481667NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6305732348
- NPI enumeration date
- July 21, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (919) 350-8000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 70
- Medical school graduation
- 1982
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Mark Leo Graham II practices at WakeMed Raleigh Campus in Raleigh, North Carolina
Dr. Graham's primary practice is WakeMed Raleigh Campus, at 3000 New Bern Ave, Raleigh, NC 27610 in Wake County. The practice phone is (919) 350-8000.
- WakeMed Raleigh Campus3000 New Bern Ave, Raleigh, NC 27610 · Wake CountyPhone(919) 350-8000
Source: Dmand AI Affiliation Data
Dr. Mark Leo Graham II is affiliated with 5 sites of care and 2 medical groups
Dr. Graham's primary practice is WakeMed Raleigh Campus in Raleigh, North Carolina, part of Advocate Health. Dr. Graham is also affiliated with UNC Health Rex. The medical group on file is WakeMed Physician Practices. Dmand AI also links Dr. Graham to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Mark Leo Graham II's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Graham practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| WakeMed Raleigh Campus | Available with a free account |
| +4 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Advocate Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Mark Leo Graham II is one of 420 hematologists and oncologists in North Carolina
Hematology and oncology is Dr. Graham's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Graham is licensed in North Carolina.
Specialties and state licenses
- Hematology and oncology, North CarolinaPrimary
Hematologists and oncologists near Dr. Graham
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Mark Leo Graham II billed Medicare for 1,396 services in 2024
CMS data shows 1,396 Medicare services from Dr. Graham across 10 procedure codes in 2024, for 524 Medicare patients. Medicare paid $103,499 for them.
Dr. Graham's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 1,8352024: 1,39624%
Where Dr. Graham's Medicare services took place, 2024
- In an office1,11280%
- In a facility28420%
Dr. Graham compared with the North Carolina median for hematologists and oncologists, 2024
- Dr. Graham
- North Carolina median
- Medicare services
- 1,396vs 4503.1 times
- Medicare patients
- 524vs 1802.9 times
- Part D claims
- 2,232vs 3246.9 times
Medians across 402 hematologists and oncologists in North Carolina with Dmand AI profiles that report each measure.
Dr. Graham's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Graham?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Graham and other hematologists and oncologists in North Carolina.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Mark Leo Graham II treated 524 Medicare patients in 2024, average age 77
CMS counts 524 Medicare patients who saw Dr. Graham in 2024. The largest group is 75 to 84, with 212 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Graham's median patient age at 67, with 72% women.
Dr. Graham's Medicare patients by age, 2024
Dr. Graham's Medicare patients by sex, 2024
- Women37672%
- Men14828%
Chronic conditions among Dr. Graham's Medicare patients, 2024
- High cholesterol75%
- High blood pressure74%
- Cancer73%
- Arthritis46%
- Chronic kidney disease32%
- Diabetes26%
- Ischemic heart disease26%
- Mood disorders26%
Share of Medicare patients with each condition. A patient can have several.
Dr. Graham's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 67
Patient panel by sex, all payers
- Women72%
- Men26%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Mark Leo Graham II wrote 2,588 Medicare Part D claims in 2024
In 2024, Dr. Graham wrote 2,588 Medicare Part D claims for 418 patients. 82% of them were for generic drugs. CMS names the drug for 2,232 of them, across 49 drugs with 11 or more claims each, at $3,583,455 in total drug cost. In 2023, CMS named 1,991 claims across 42 drugs.
Dr. Graham's Part D claims by kind of drug, 2024
- Generic2,131 claims82%
- Brand-name and other457 claims18%
Dr. Graham's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Graham's Part D claims, 2024
- Opioids6%146 of 2,588 claims
- Antibiotics3%71 of 2,588 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,9912024: 2,23212%
Drugs named by CMS: 49 in 2024, 42 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Mark Leo Graham II offers telehealth to Medicare patients
Dr. Graham accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Graham as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Mark Leo Graham II has 7 publications on record
Dmand AI links 7 papers to Dr. Graham, published from 2011 to 2021. 2018 was the busiest year, with 2. The most frequent topics are Breast Neoplasms, Genotype and Tamoxifen. Dr. Graham's most frequent co-authors are Steven William Corso, MD, James P. Evans, MD and Oludamilola Abidemi Olajide, MD.
Dr. Graham's papers by year, 2011 to 2021
Topics Dr. Graham writes about most
- Breast Neoplasms
- Genotype
- Tamoxifen
Dr. Graham's most frequent co-authors
- Steven William Corso, MD2 shared papers
- James P. Evans, MD2 shared papers
- Oludamilola Abidemi Olajide, MD2 shared papers
Recent publications by Dr. Graham
See who Dr. Graham researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Graham works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Mark Leo Graham II has worked on 10 clinical trials
Dmand AI links Dr. Graham to 10 clinical trials, 6 of them phase 3 studies. 9 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Leukemia, Lymphocytic, Chronic, B-Cell. National Cancer Institute (NCI) sponsors the most, 4. Open Payments lists research payments to Dr. Graham that name 1 trial.
Clinical trials with Dr. Graham by phase
- NonePhase 1: no trials
- 1Phase 2: 1 trial
- 6Phase 3: 6 trials
- NonePhase 4: no trials
Conditions in Dr. Graham's trials
- Breast Neoplasms
- Breast Diseases
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, B-Cell
- Carcinoma, Intraductal, Noninfiltrating
Investigators on the most trials with Dr. Graham
- Lara Natasha Durna, MD6 shared trials
- Shalini Mulaparthi, MD5 shared trials
- Blair Ardman, MD4 shared trials
Recent clinical trials with Dr. Graham
Optimizing Endocrine Therapy Through Motivational Interviewing and Text Interventions (opens in a new tab)
Longitudinal Assessment of Financial Burden in Patients With Colon or Rectal Cancer Treated With Curative Intent (opens in a new tab)
Assessing the Ability of Combination Treatment With Venetoclax to Permit Time Limited Therapy in Chronic Lymphocytic Leukemia (opens in a new tab)
Testing the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Mark Leo Graham II received $5,078 in industry payments from 2016 to 2025
CMS Open Payments shows 261 general payments to Dr. Graham from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Eli Lilly and Company paid the most, $642. It also lists 5 research payments totaling $21,613 from 2017 to 2020, naming 1 clinical trial.
General payments to Dr. Graham by program year, 2016 to 2025
General payments to Dr. Graham by kind, 2016 to 2025
- Food and beverage$4,63291%
- Education$2405%
- Travel and lodging$2064%
Companies that paid Dr. Graham the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Mark Leo Graham II graduated from Mayo Medical School
Dr. Graham graduated from Mayo Medical School in 1982.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Mark Leo Graham II's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Mark Leo Graham II
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Mark Leo Graham II's NPI number?
Dr. Mark Leo Graham II's NPI number is 1760481667. It was assigned on July 21, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Mark Leo Graham II?
Dr. Mark Leo Graham II is a hematologist and oncologist in Raleigh, North Carolina. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Mark Leo Graham II practice?
Dr. Graham practices at 3000 New Bern Ave, Raleigh, NC 27610. Dr. Graham's primary practice is WakeMed Raleigh Campus in Raleigh, North Carolina, part of Advocate Health. Dmand AI also links Dr. Graham to 1 hospital, 2 group practices and clinics and 1 medical group.
What is Dr. Mark Leo Graham II's office phone number?
The practice phone on file for Dr. Graham is (919) 350-8000.
What is Dr. Mark Leo Graham II's medical license number?
Dr. Graham holds North Carolina license 39812.
Which hospitals is Dr. Mark Leo Graham II affiliated with?
Dr. Graham practices at WakeMed Raleigh Campus in Raleigh, North Carolina. Dr. Graham is also affiliated with UNC Health Rex. Dmand AI links Dr. Graham to 1 more hospital.
What medical group is Dr. Mark Leo Graham II part of?
Dr. Graham is linked to WakeMed Physician Practices. Dmand AI links Dr. Graham to 1 more medical group.
Does Dr. Mark Leo Graham II accept Medicare?
Yes. CMS data shows Dr. Graham billed Medicare for 1,396 services in 2024, and Dr. Graham accepts Medicare assignment.
Does Dr. Mark Leo Graham II offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Graham as offering telehealth services.
How many Medicare patients does Dr. Mark Leo Graham II see?
CMS counts 524 Medicare patients who saw Dr. Graham in 2024, with an average age of 77.
Show 7 more questionsShow fewer questions
What services does Dr. Mark Leo Graham II bill to Medicare?
In 2024, Dr. Graham's most billed Medicare services were office visit, established patient (99214), hospital inpatient care (99232) and hospital inpatient care (99233).
Where did Dr. Mark Leo Graham II go to medical school?
Dr. Graham graduated from Mayo Medical School in 1982.
What drugs does Dr. Mark Leo Graham II prescribe most?
In 2024 Medicare Part D data, Dr. Graham's most prescribed drugs by claims were Anastrozole, Tamoxifen Citrate and Ibandronate Sodium.
Has Dr. Mark Leo Graham II received payments from drug or device companies?
CMS Open Payments shows $5,078 in general payments to Dr. Graham from 40 companies from 2016 to 2025. The largest total came from Eli Lilly and Company.
How long has Dr. Mark Leo Graham II been practicing?
Dr. Graham graduated from medical school in 1982, 44 years ago.
Does Dr. Mark Leo Graham II do research?
Dmand AI links 7 publications to Dr. Graham, published from 2011 to 2021. Dr. Graham has worked on 10 clinical trials.
Who does Dr. Mark Leo Graham II publish with?
Dr. Graham's most frequent co-authors are Steven William Corso, MD (2 shared papers), James P. Evans, MD (2 shared papers) and Oludamilola Abidemi Olajide, MD (2 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in North Carolina by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card